M
MBX Biosciences, Inc. (MBX)
NMS – Real Time Price. Currency in USD
36.98
-3.10 (-7.73%)
At close: May 12, 2026, 4:00 PM EDT
38.15
+1.17 (3.16%)
After-hours: May 12, 2026, 7:28 PM EDT
Find any stock by ticker or company name

NMS – Real Time Price. Currency in USD
36.98
-3.10 (-7.73%)
At close: May 12, 2026, 4:00 PM EDT
38.15
+1.17 (3.16%)
After-hours: May 12, 2026, 7:28 PM EDT
| Breakdown | |
|---|---|
| 2.71% | % of Shares Held by All Insider |
| 109.46% | % of Shares Held by Institutions |
| 112.50% | % of Float Held by Institutions |
| 196 | Number of Institutions Holding Shares |
| Holder | Shares | Date Reported | % Out | Value |
|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 6.65M | 2025-12-31 | 13.98% | $272.50M |
| Orbimed Advisors LLC. | 3.94M | 2025-12-31 | 8.27% | $161.21M |
| NEA Management Company, LLC | 3.61M | 2025-12-31 | 7.60% | $148.07M |
| Wellington Management Group, LLP | 3.35M | 2025-12-31 | 7.04% | $137.23M |
| Deep Track Capital, Lp | 3.25M | 2025-12-31 | 6.83% | $133.13M |
| Blackrock Inc. | 2.92M | 2025-12-31 | 6.14% | $119.61M |
| NVP Associates, LLC | 2.14M | 2025-12-31 | 4.49% | $87.51M |
| EcoR1 Capital, LLC | 2.12M | 2025-12-31 | 4.46% | $86.99M |
| Vanguard Group Inc | 1.82M | 2025-12-31 | 3.82% | $74.47M |
| Driehaus Capital Management, LLC | 1.41M | 2025-12-31 | 2.96% | $57.69M |
| Holder | Shares | Date Reported | % Out | Value |
|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.06M | 2025-12-31 | 2.22% | $43.34M |
| MUTUAL FUND SERIES TRUST-Eventide Healthcare & Life Sciences Fund | 890,000 | 2025-12-31 | 1.87% | $36.46M |
| iShares Trust-iShares Russell 2000 ETF | 692,013 | 2026-03-31 | 1.45% | $28.35M |
| T. Rowe Price Health Sciences Fund, Inc. | 615,715 | 2025-12-31 | 1.29% | $25.22M |
| Fidelity Capital Trust-Fidelity Stock Selector Small Cap Fund | 414,400 | 2026-02-28 | 0.87% | $16.98M |
| Franklin Strategic Series-FRANKLIN SMALL CAP GROWTH FUND | 348,601 | 2025-10-31 | 0.73% | $9.58M |
| BlackRock Funds-BLACKROCK HEALTH SCIENCES OPPORTUNITIES PORTFOLIO | 340,569 | 2025-11-30 | 0.72% | $10.88M |
| BlackRock Funds-BlackRock Health Sciences Opportunities Portfolio | 333,350 | 2026-02-28 | 0.70% | $13.66M |
| Franklin Strategic Series-FRANKLIN BIOTECHNOLOGY DISCOVERY FUND | 323,190 | 2025-10-31 | 0.68% | $8.88M |
| Fidelity Hastings Street Trust-Fidelity Fund | 321,100 | 2026-03-31 | 0.67% | $13.15M |
| Fidelity Advisor Series VII-Fidelity Advisor Biotechnology Fund | 304,600 | 2026-03-31 | 0.64% | $12.48M |
| Fidelity Securities Fund-Fidelity Series Small Cap Opportunities Fund | 303,100 | 2026-02-28 | 0.64% | $12.42M |
| Fidelity Securities Fund-Fidelity Small Cap Growth Fund | 301,640 | 2026-02-28 | 0.63% | $12.36M |
| Variable Insurance Products Fund II-VIP Contrafund Portfolio | 286,900 | 2026-02-28 | 0.60% | $8.45M |
| Fidelity Select Portfolios-Select Health Care Portfolio | 280,000 | 2026-02-28 | 0.59% | $8.24M |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 276,251 | 2026-01-31 | 0.58% | $8.13M |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 271,501 | 2025-12-31 | 0.57% | $8.09M |
| iShares Trust-iShares Russell 2000 Value ETF | 243,159 | 2026-03-31 | 0.51% | $7.24M |
| HARTFORD MUTUAL FUNDS INC/CT-THE HARTFORD HEALTHCARE FUND | 225,661 | 2025-10-31 | 0.50% | $7.14M |
| iShares Trust-iShares Biotechnology ETF | 195,237 | 2026-01-31 | 0.41% | $5.70M |